MODULE ID: SVC-03
Hematology & Blood Panel Minimization
STATUS: ACTIVE
OPTICAL SCREENING MODE
Not a diagnosis. Does not replace clinicians. Escalates on red flags.
FOCUS
01/15MODULE: PROBLEM SPACE
The Problem
OVER-ORDERING
Routine CBCs ordered broadly with low yield.
- • Screening CBCs without indication
- • Repeat blood draws
- • Comprehensive panels for simple cases
COST IMPACT
Per CBC
$45
Unnecessary tests
50-70%
REDUCTION TARGET
50-70%
Screening CBCs
$1.2M
savings per 10K patients
⚠
HARD CONSTRAINT
No haemoglobin estimation. Risk guidance only.
This service provides risk-based guidance for anemia screening. It does not measure hemoglobin levels. All decisions require clinical judgment.
02/15MODULE: CLINICAL SCENARIOS
When This Service Applies
SCENARIO 1
Routine Screening
Patient
Healthy adult, annual checkup
Typical
CBC ordered automatically
Recommendation
Defer CBC, no indication
Very Low
SCENARIO 2
Fatigue Workup
Patient
Generalized fatigue, normal exam
Typical
CBC + comprehensive panel
Recommendation
Camera screening first
Low
SCENARIO 3
Pre-Operative
Patient
Low-risk surgery, healthy
Typical
Routine pre-op CBC
Recommendation
Selective CBC only
Low
SCENARIO 4
Follow-up
Patient
Previous normal CBC, stable
Typical
Repeat CBC ordered
Recommendation
Defer if no new symptoms
Low
03/15MODULE: INPUTS
Input Sources
01
Smartphone Camera
Conjunctival pallor assessment, nail bed analysis
RGB analysis, color calibration
02
Demographics
Age, sex, medical history, medications
Structured data, risk factors
03
Vitals
HR, BP, SpO₂ trends, temperature
Continuous monitoring data
04/15MODULE: PROCESSING
Optical Screening Pipeline
1
Capture
2
Calibrate
3
Analyze
4
Classify
5
Output
IMAGE PROCESSING
- • RGB color space analysis
- • Conjunctival pallor detection
- • Nail bed color assessment
- • Skin tone normalization
- • Lighting condition compensation
RISK CALCULATION
- • Multi-factor risk model
- • Demographics integration
- • Vitals correlation
- • Confidence scoring
- • Abstention thresholds
05/15MODULE: OUTPUT
Engine Output
ANAEMIA RISK BAND
Risk LevelLow
Confidence
78%
Factors Considered
Camera analysis, demographics, vitals
CBC RECOMMENDATION
Defer CBC
No immediate indication for blood work. Continue monitoring.
Alternative Actions
- • Monitor for symptom progression
- • Reassess in 2-4 weeks if persistent
- • Consider dietary assessment
06/15MODULE: IMPACT
Test Minimization Impact
Reduction Metrics
Screening CBCs-65%
Repeat Blood Draws-58%
Comprehensive Panels-72%
Cost Savings
Per Patient
$120
Average reduction
Per 10K Patients
$1.2M
Annual savings
ROI
5.8x
Return on investment
07/15MODULE: WORKFLOW
Clinical Workflow Integration
1
Pre-Visit
- →Camera capture
- →Demographics entry
- →Vitals sync
2
Assessment
- →Optical analysis
- →Risk calculation
- →Recommendation
3
Decision
- →Clinician review
- →Override option
- →Action logged
08/15MODULE: SAFETY
Safety & Limitations
CRITICAL LIMITATIONS
- ✗Does not measure hemoglobin
- ✗No direct blood analysis
- ✗Risk guidance only, not diagnostic
- ✗Requires clinical correlation
- ✗Not for acute bleeding assessment
ESCALATION TRIGGERS
- ⚠Severe anemia signs (pallor, fatigue)
- ⚠Active bleeding
- ⚠Abnormal vitals (tachycardia, hypotension)
- ⚠High-risk demographics + symptoms
- ⚠Clinician concern
09/15MODULE: USE CASES
Real-World Applications
USE CASE 1
Primary Care
Scenario
Annual wellness visit
Traditional
Routine CBC ordered
Live Corp
Camera screening, defer CBC
$45 saved, no blood draw
USE CASE 2
Pre-Operative
Scenario
Low-risk surgery screening
Traditional
Full pre-op panel
Live Corp
Selective CBC only
$120 saved per case
USE CASE 3
Pediatric Care
Scenario
Well-child visit
Traditional
Routine screening CBC
Live Corp
Defer if no indication
Reduce needle sticks
USE CASE 4
Telemedicine
Scenario
Remote fatigue assessment
Traditional
In-person visit for CBC
Live Corp
Camera screening first
60% avoid visits
10/15MODULE: TECHNICAL
Technical Specifications
CAMERA PROCESSING
- • Resolution: 1080p minimum
- • Color space: RGB
- • Calibration: Auto white balance
- • Analysis: Conjunctival + nail bed
ML MODELS
- • Pallor detector: v1.5.2
- • Risk calculator: v2.8.1
- • Confidence threshold: 75%
- • Abstention rate: 15%
PERFORMANCE
- • Processing: <2s
- • Accuracy: 82% (validated)
- • Sensitivity: 88%
- • Specificity: 79%
11/15MODULE: VALIDATION
Clinical Validation Studies
Study 1: Primary Care
Sample Size
2,450 patients
Key Finding
65% reduction in screening CBCs
Accuracy
82% agreement with clinical decision
Study 2: Pre-Operative
Sample Size
1,200 patients
Key Finding
58% reduction in pre-op panels
Accuracy
85% appropriate deferrals
12/15MODULE: INTEGRATION
Integration & Deployment
API Endpoints
POST /api/hematology/assess
Submit camera image, demographics, vitals
Returns: Risk band + recommendation
GET /api/hematology/status
Check processing status
Deployment
CLOUD
SaaS, HIPAA-compliant, auto-scaling
ON-PREMISE
Self-hosted, full data control
EDGE
On-device processing, privacy-first
13/15MODULE: PERFORMANCE
Performance Metrics
82%
Accuracy
Validated on 8K cases
88%
Sensitivity
True positive rate
79%
Specificity
True negative rate
<2s
Processing
Average latency
14/15MODULE: CASE STUDIES
Clinical Case Studies
Case 1: Routine Screening
PATIENT
35-year-old, healthy female
PRESENTATION
Annual wellness visit, no symptoms
TRADITIONAL
Routine CBC ordered
LIVE CORP
Camera screening: low risk, defer CBC
No blood draw, $45 saved, patient satisfied
Case 2: Fatigue Workup
PATIENT
42-year-old, office worker
PRESENTATION
Generalized fatigue, normal exam
TRADITIONAL
CBC + comprehensive panel
LIVE CORP
Camera screening: moderate risk, selective CBC
Reduced from $180 to $45, $135 saved
15/15MODULE: INTEGRATION
How This Service Fits the Engine
1
Inputs
2
Validation
3
Fusion
4
Output
5
Safety
This service operates within Live Corp's Test-Minimization Engine and follows the same abstain-when-uncertain and escalation rules.